Trial intelligence / Profile preview

Ropivacaine versus lidocaine for pain control in impacted lower third molar extraction

RBR-7wyqr7Phase 2Completed

Sponsor
Faculdade de Ciências da Saúde
Start
Apr 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ropivacaine and lidocaine in Impacted lower third molar (2 arms), sponsored by Faculdade de Ciências da Saúde. Started Apr 2016; status: completed.

02

Drugs

ropivacainelidocaine
03

Conditions

Impacted lower third molar

Beyond the preview

Go deeper on RBR-7wyqr7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7wyqr7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call